본문으로 건너뛰기
← 뒤로

Recalibrating the evidence level in hepatocellular carcinoma: Integrating efficacy and effectiveness of immunotherapy.

0/5 보강
iLIVER 2025 Vol.4(4) p. 100200
Retraction 확인
출처

Wu H, Xu XF, Law JH, Yang T

이 논문을 인용하기

↓ .bib ↓ .ris
APA Wu H, Xu XF, et al. (2025). Recalibrating the evidence level in hepatocellular carcinoma: Integrating efficacy and effectiveness of immunotherapy.. iLIVER, 4(4), 100200. https://doi.org/10.1016/j.iliver.2025.100200
MLA Wu H, et al.. "Recalibrating the evidence level in hepatocellular carcinoma: Integrating efficacy and effectiveness of immunotherapy.." iLIVER, vol. 4, no. 4, 2025, pp. 100200.
PMID 41342011 ↗

같은 제1저자의 인용 많은 논문 (5)

🟢 PMC 전문 열기